Senior Director, Global Marketing Cell Therapy

AstraZeneca; Gaithersburg (MD); On-site; USD 250,000 - 360,000; Full time

Job summary

AstraZeneca seeks a Senior Director, Global Marketing for Cell Therapy to shape and drive the global commercial strategy across multiple indications. You will translate emerging evidence and patient needs into differentiated development and commercialization plans in a fast-growing cell therapy portfolio.

You will partner across R&D, Medical, Market Access, Regulatory, Manufacturing, and country teams to deliver launch-ready programs, optimize resource allocation, and ensure brand consistency,

Qualifications

• Minimum 8 years in pharma/healthcare marketing or commercial leadership.
• Experience with cell therapy, gene therapy, or advanced therapy is a plus.
• Global experience across major markets is advantageous.

Responsibilities

• Develop global brand strategy and launch plans for Cell Therapy.
• Build global capabilities and customer journeys to support launch readiness.
• Translate strategy into region-specific implementation plans.
• Partner with Medical, Market Access, Clinical, Regulatory, Analytics & Insights, Manufacturing, Supply, and country teams.
• Manage budgets and external agencies for brand and launch activities.

Skills

Brand marketing

Launch planning

Cross-functional leadership

Strategic planning

Commercial analytics

Education

Bachelor's in a scientific field

MBA or PharmD preferred

Job description

Within the AstraZeneca Cell Therapy Enterprise, our ambition is to realize the full potential of cell therapy for people living with cancer, immune-mediated and rare diseases around the world. This unit has responsibility for the value chain from discovery through to late-stage development and commercialization. We are rapidly progressing a broad pipeline of cell therapies in collaboration with AstraZeneca's Therapeutic Area Units.

We have an exciting opportunity to work in the Global Cell Therapy Franchise as the Senior Director, Global Marketing, Cell Therapy . This role, reporting into the Global Commercial Head for Cell Therapy, will help shape and drive the global commercial strategy for the cell therapy portfolio across multiple indications, translating emerging evidence, patient needs, and market insights into differentiated development and commercialization strategies.

This role is a pivotal opportunity within the Cell Therapy Enterprise and a key contributor to our ambition to transform outcomes for patients with serious diseases. You will shape the early commercial strategy for a promising cell therapy asset or disease area within the Cell Therapy portfolio, which spans hematology, oncology, autoimmune disease, and rare diseases. This will require partnering across Research & Development, Clinical, Medical, Market Access, Regulatory, Manufacturing, Supply, and country teams. You will help define differentiated treatment delivery models, patient pathways, launch capabilities, and go-to-market strategies, ensuring commercial considerations are embedded throughout development. You bring a strategic and enterprise mindset, commercial acumen, and the ability to translate emerging evidence, unmet need, and market dynamics into differentiated development and commercialization choices.

Who you are

You're energized by building rather than maintaining - comfortable defining the playbook for a new modality rather than inheriting one. You move fluidly between rigorous, data-driven brand strategy and hands-on execution. You partner without needing full authority, translate ambiguity into a clear point of view, and bring the curiosity, collaboration, and integrity that define the Cell Therapy Enterprise

Key Responsibilities

• Develop the global brand strategy and launch plan for Cell Therapy, including positioning, promotional strategy, and the go-to-market model.
• Build the global capabilities, customer journeys, and treatment delivery models required to support launch readiness and execution.
• Translate global strategy into clear implementation plans for regions and priority markets.
• Partner across Medical, Market Access, Patient Affairs, Clinical, Regulatory, Analytics & Insights, Manufacturing, Supply, and country teams to align development and commercialization plans.
• Integrate commercial insights-market opportunity, customer needs, competitive positioning, pricing, access, and treatment-delivery considerations-into development, regulatory, and portfolio decisions.
• Serve as the commercial subject matter expert, enabling markets and cross-functional partners to execute the strategy and launch playbook effectively.
• Track launch-readiness, site activation, treatment delivery, customer experience, and other relevant KPIs; provide performance insights and recommendations.
• Maintain brand consistency across marketing initiatives and communications.
• Manage the global brand budget and optimize resource allocation.
• Manage relationships and budgets with external agency partners to execute the brand and launch strategy.

Requirements / Qualifications

• Minimum 8 years of experience in the pharmaceutical and/or healthcare industry across brand marketing, sales, market research, analytics, strategic planning, or commercial leadership.
• Direct cell therapy, gene therapy, or advanced therapy experience. Global experience across major markets is an advantage.
• Experience leading multiple indications simultaneously.
• Broad global commercial experience including pre-launch and launch.
• Experience shaping early commercial strategy and influencing development decisions for pre-launch or pipeline assets.
• Demonstrated use of insights to develop effective commercial strategies.
• Demonstrated ability to develop compelling business cases and influence senior stakeholders.
• Ability to simultaneously manage multiple priorities with a high degree of autonomy.
• Bachelor's degree in a relevant scientific discipline; MBA, PhD, PharmD, or other advanced degree preferred.

At AstraZeneca, we are on a journey to bring life-saving medicines to patients. Our role in contributing to decreasing mortality rates globally is clear. We are shaping the future by spotting scientifically-led commercial opportunities and acting now to operationalize and scale them. We are driven by the solutions we bring to the healthcare ecosystem. It powers us to make an impact at every step of the patient journey. We are constantly thinking big to answer new challenges. We p